Expert Interview
A Second Look: Prime editing compared to CRISPR/Cas9 gene editing and its potential in future therapeutics
Ticker(s): PRME, VRTX, CRSPInstitution: The Rockefeller University
- Professor at The Rockefeller University and Investigator at Howard Hughes Medical Institute
- Honored for his pioneering research on the study of CRISPR-Cas systems as one of the first investigators to characterize the function of CRISPR-Cas in bacteria (Marraffini and Sontheimer, Science 2008) and to apply CRISPR-Cas9 for genome editing of human and bacterial cells.
- His research investigates how CRISPR-Cas systems provide adaptive immunity to bacteria and helped lay the groundwork for the newly FDA-approved CRISPR-based therapy for sickle cell anemia.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
